Food and Drug Administration's (FDA)

US FDA approves Pfizer's drug for rare bleeding disorder

The drug, Hympavzi, is given under the skin through an auto-injector pen to prevent or reduce bleeding episodes in hemophilia A or B patients aged 12 years and older

Food and Drug Administration's (FDA)

Food and Drug Administration's (FDA)

US FDA approves Pfizer's drug for rare bleeding disorder

Hundreds of coffee products recalled in US over fears of potentially deadly toxin

Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA